Plexus (PLXS)
(Delayed Data from NSDQ)
$136.95 USD
+3.09 (2.31%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $136.29 -0.66 (-0.48%) 4:50 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$136.95 USD
+3.09 (2.31%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $136.29 -0.66 (-0.48%) 4:50 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Zacks News
Plexus (PLXS) Up 0.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fiscal third-quarter results reflect lower revenues from Healthcare/Life Sciences and Industrial markets despite strict cost control.
Plexus (PLXS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 28.57% and 1.78%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Plexus (PLXS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Likely to Miss Q3 View on Restrictions in Malaysia
by Zacks Equity Research
Plexus (PLXS) anticipates that it won't be able to meet earlier provided third-quarter fiscal 2021 earnings and revenue guidance.
Plexus (PLXS) Up 10.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Plexus (PLXS) Might be Well Poised for a Surge
by Zacks Equity Research
Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The Zacks Analyst Blog Highlights: Arrow Electronics, Avnet, Jabil, Plexus and SMART Global Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Arrow Electronics, Avnet, Jabil, Plexus and SMART Global Holdings
These 5 Tech Stocks Offer Growth at Reasonable Valuations
by Sejuti Banerjea
Big tech has been hammered this month, but there are plenty more fish in the sea.
Plexus (PLXS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Plexus (PLXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Plexus (PLXS) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Plexus (PLXS) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
4 Buy-Ranked Tech Companies That Reported Solid Earnings
by Sejuti Banerjea
Tech earnings appear to be tracking above expectations so far, while revenues lag.
Plexus (PLXS) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fiscal second-quarter results reflect benefits from steady Healthcare/Life Sciences and Industrial markets and strict cost control.
Plexus (PLXS) Q2 Earnings Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 19.20% and -0.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Plexus (PLXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Plexus (PLXS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Plexus (PLXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Plexus (PLXS) Up 1.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Plexus (PLXS) a Great Stock for Value Investors?
by Zacks Equity Research
Is Plexus (PLXS) a great pick from the value investor's perspective right now? Read on to know more.
Is Plexus (PLXS) a Great Stock for Value Investors?
by Zacks Equity Research
Is Plexus (PLXS) a great pick from the value investor's perspective right now? Read on to know more.
Equity Market Set to Rally: Buy These 5 Low Leverage Stocks
by Aparajita Dutta
A prudent investor should always analyze the debt value of a company before choosing it. You may consider adding JHG, PLXS, ASIGI, DHI, ACLS to your portfolio currently.
Zacks.com featured highlights include: DICKS Sporting Goods, Plexus Corp, ASML Holding, D.R. Horton and Lennar Corp
by Zacks Equity Research
Zacks.com featured highlights include: DICKS Sporting Goods, Plexus Corp, ASML Holding, D.R. Horton and Lennar Corp
Buy These 5 Low Leverage Stocks to Avoid Portfolio Losses
by Aparajita Dutta
To avoid huge losses, a prudent investor should always go for stocks that bear low leverage since a debt-free corporation is rare to find. You may consider adding DKS, PLXS, ASML, DHI, LEN to your portfolio currently.
Plexus (PLXS) Q1 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Plexus' (PLXS) fiscal first-quarter results reflect benefits from steady Healthcare/Life Sciences and Industrial markets and strict cost control.
Plexus (PLXS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 10.81% and 0.02%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.